First Merchants Corp Has $688,000 Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

First Merchants Corp reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.7% in the 1st quarter, Holdings Channel.com reports. The firm owned 5,383 shares of the financial services provider’s stock after selling 150 shares during the quarter. First Merchants Corp’s holdings in iShares Biotechnology ETF were worth $688,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently bought and sold shares of IBB. Brighton Jones LLC bought a new stake in iShares Biotechnology ETF in the 4th quarter valued at $201,000. Bank Pictet & Cie Europe AG increased its holdings in iShares Biotechnology ETF by 6.1% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 17,280 shares of the financial services provider’s stock valued at $2,285,000 after buying an additional 1,000 shares during the period. Y Intercept Hong Kong Ltd bought a new stake in iShares Biotechnology ETF in the 4th quarter valued at $511,000. Kovack Advisors Inc. increased its holdings in iShares Biotechnology ETF by 5.3% in the 4th quarter. Kovack Advisors Inc. now owns 2,060 shares of the financial services provider’s stock valued at $272,000 after buying an additional 104 shares during the period. Finally, Oppenheimer & Co. Inc. increased its holdings in iShares Biotechnology ETF by 32.8% in the 4th quarter. Oppenheimer & Co. Inc. now owns 47,361 shares of the financial services provider’s stock valued at $6,262,000 after buying an additional 11,698 shares during the period. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of iShares Biotechnology ETF stock opened at $126.47 on Friday. The company’s fifty day moving average price is $123.73 and its two-hundred day moving average price is $129.46. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $150.57.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.